Follow this link to go immediately to the page content.
ASI Logo Happy Children Header
Supporting those affected by Alström Syndrome

   General information

   Alström Syndrome International

       • About ASI

       • What's New at ASI

       • ASI Conferences

       • How you can help

       • Countries Served by ASI

       • Board of Directors

       • Scientific Advisory Board

   For Families

       • What is Alström Syndrome?

       • Spotlight -- Good News!

       • Information and Resources

       • Genetics of Alström

       • Memorials

   For Professionals

       • Clinical Features

       • Guidelines

       • Medical Literature

       • Research

   Contact Us


   Alström Syndrome Home


 

 

Logo: Certified Medinex Health Site

Logo: HONcode Principles of the Health on the Net Foundation
We subscribe to the HONcode principles of the Health On the Net Foundation.
Verify your site here
.
 

Towards understanding the molecular basis of Alström syndrome

Gayle B. Collin1, Jan D. Marshall, Akihiro Ikeda, W Venus So, Isabelle Russell- Eggitt, Pietro Maffei, Sebastian Beck, Cornelius F. Boerkoel, Nicola Sicolo, Mitchell Martin, Patsy M. Nishina, Jürgen K. Naggert

Alström syndrome (AS), a homogeneous autosomal recessive disorder, is characterized by childhood obesity associated with hyperinsulinemia, chronic hyperglycemia, and neurosensory deficits. Using a positional cloning strategy, we identified a novel transcript, KIAA0328, in which mutation analysis revealed sequence variations in patients with Alström syndrome. ALMS1 is a novel gene that is ubiquitously expressed at low levels and does not share significant sequence homology with other genes reported thus far. To date, we have identified mutations in 32 out of 62 kindreds screened. In total, 23 discrete nonsense and/or frameshift mutations have been observed, with the majority occurring in exon 16.

Subsets of Alström patients exhibit additional clinical features including dilated cardiomyopathy, hepatic dysfunction, hyperuricemia, hypothyroidism, male hypogonadism, short stature, and mild to moderate developmental delay. Phenotypic variation has also been observed within sibships which suggests that the disease manifestion of Alström syndrome is influenced by a combination of genetic and/or environmental factors. To dissect the genetic modifiers which interact with ALMS1, several mouse knockout models including a conditional knockout are being constructed in our laboratory. Mouse models are also being used to study the disease pathology and progression of AS. We have performed in situ hybridization and immunohistochemistry in various mouse tissues and in cell culture to elucidate the temporal and spatial expression pattern of ALMS1 . Studying the ALMS1 gene and determining the biochemical pathway in which it functions will assist toward a better understanding of both Alström syndrome and the common diseases that characterize it phenotypically.

  1. The Jackson Laboratory, Bar Harbor, ME 04609, USA
  2. Computational Genomics and Genetics, Hoffmann-La Roche, Inc., Nutley, NJ 07710, USA
  3. Great Ormond Street Hospital, London, UK WCIN 3JH
  4. Insituto di Semeiotica Medica, 35100 Padova, Italy
  5. Insituto Nacional de Saude, P-1649-016 Lisbon, Portugal
  6. Baylor College of Medicine, Houston, TX 77030, USA
Follow this link to return to the main site navigation.
spacer: keeps table column a constand width
Home - General Information - Alstr öm Syndrome International
For Families - For Professionals

Last Modified: June 23, 2008  

ASI Home